Policy Options for the Drug Pricing Conundrum

Kate Ho and Ariel Pakes

No 32606, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: Current proposals aimed at reducing U.S. pharmaceutical prices would have immediate benefits (particularly for low-income and elderly populations), but are likely to dramatically reduce firms’ investment in highly welfare-improving R&D. The U.S. subsidizes the worldwide pharmaceutical market: U.S. drug prices are more than 250% of those in other OECD countries. If each drug had a single international price across the highest-income OECD countries and total pharmaceutical firm profits were held fixed: U.S. prices would fall by half; every other country’s prices would increase (by 28 to over 300%); and R&D incentives would be maintained. We propose a potential lever for the U.S. government to influence worldwide drug pricing: access to the Medicare market.

JEL-codes: I18 L20 (search for similar items in EconPapers)
Date: 2024-06
New Economics Papers: this item is included in nep-com, nep-hea and nep-reg
Note: EH IO
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.nber.org/papers/w32606.pdf (application/pdf)
Access to the full text is generally limited to series subscribers, however if the top level domain of the client browser is in a developing country or transition economy free access is provided. More information about subscriptions and free access is available at http://www.nber.org/wwphelp.html. Free access is also available to older working papers.

Related works:
Journal Article: Policy options for the drug pricing conundrum (2025)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:32606

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w32606
The price is Paper copy available by mail.

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().